China's WuXi AppTec will raise $500 million in a convertible bond sale, according to a regulatory filing on Tuesday, a month ...

China's WuXi AppTec , will raise $500 million in a convertible bond sale, according to a regulatory filing on Tuesday, a ...

WuXi AppTec Co.’s shares had their worst day in seven months, after the company sold a $500 million convertible bond the day ...

Drugmakers have been targeted on national security grounds and could lose customers if Congress passes Biosecure Act ...

WuXi AppTec has put its cell and gene therapy manufacturing unit WuXi Advanced Therapies, which operates four laboratories ...

WuXi AppTec has put its cell and gene therapy manufacturing arm WuXi Advanced Therapies, which operates four laboratories and ...

WuXi AppTec looks to unload its Philadelphia manufacturing sites and WuXi Biologics slows its rapid expansion in the U.S. as ...

A hospital in Wuxi, Jiangsu province, is suspected of illegally using medical insurance funds totaling nearly 22.3 million ...

As the BIOSECURE Act works its way through the U.S. legislative branch, two companies named in the bill are reportedly ...

The gains were made on the back of a report that said the two firms plan to sell certain overseas operations amid heightened ...

WuXi is considering the sale of some US and European operations to mitigate the impact of upcoming restrictions.

Ahead of the BIOSECURE Act, WuXi AppTec is in talks to sell its Philadelphia-based cell and gene therapy unit, and WuXi ...